Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer
NCT ID: NCT00466830
Last Updated: 2025-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2005-09-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This clinical trial is studying the psychological and social factors that may increase the risk of developing chronic pain after surgery in women with breast cancer .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Persistent Post-Surgical Pain in Women With BrCA
NCT02266082
Chronic Pain and Minor Breast Cancer Surgery
NCT03912948
Chronic Pain in Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
NCT00971919
Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer
NCT02944721
Genetic, Neurophysiological and Psychological Risk Factors for Neuropathic Pain
NCT02368275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary : Determine the psychological and sociological factors that predispose post-mastectomy pain syndrome after surgery in women with resectable breast cancer.
Secondary
* Determine the psychological and sociological factors that predispose post-surgical pain in these patients.
* Evaluate emotional distress over time in these patients.
* Evaluate the acute and chronic pain over time in these patients.
This is a multicenter study. Patients complete multiple questionnaires, including Hospital Anxiety and Depression Scale (HAD), Maudsley Personality Inventory (MPI), PCS, and QLQ-C30, to evaluate psychological variables (alexithymia, neurosis, repression of negative emotions, solicitude, dramatization, emotional distress) and quality of life.
Post-mastectomy chronic pain (PMCP) syndrome is measured immediately after surgery and at 24 hours, day 6, and 5 months post-surgery.
A subgroup of patients (20 with PMCP and 20 without PMCP) are followed at months 5 and 6 months post-surgery for medication use, pathological problems, morbid events, family history, and environmental factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire administration
management of therapy complications
psychosocial assessment and care
quality-of-life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of breast cancer
* Mastectomy or lumpectomy, including axillary lymph node dissection, planned
* Analgesic fixed (or ordered) the morning of surgery
* No stage III analgesic planned
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Female
* Menopausal status not specified
* WHO performance status 0-2
* Other prior malignancy allowed
* No American Society of Anesthesiologists' class IV
* No contraindication or drug addiction
* No uncontrolled conditions, including any of the following:
* Diabetes
* Thyroid disease
* Neuropsychiatric disease
* Infection
* Insufficient coronary function
* NYHA class III-IV heart disease
PRIOR CONCURRENT THERAPY:
* No recent major surgery
* No participation in another medical or surgical clinical trial in the past 30 days
* Prior breast surgery for a benign lesion or malignant lesion allowed
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut BergoniƩ
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence Dixmerias, MD
Role: STUDY_CHAIR
Institut BergoniƩ
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IB-2005-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.